These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10403929)

  • 1. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
    Schwabe RF; Engelmann H; Hess S; Fricke H
    Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.
    Contin C; Pitard V; Delmas Y; Pelletier N; Defrance T; Moreau JF; Merville P; Déchanet-Merville J
    Immunology; 2003 Sep; 110(1):131-40. PubMed ID: 12941150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients.
    Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A
    Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying sCD40 production in hemodialysis patients.
    Esposito P; Rampino T; Gregorini M; Gabanti E; Bianzina S; Dal Canton A
    Cell Immunol; 2012; 278(1-2):10-5. PubMed ID: 23121970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune status of uraemic children/adolescents with chronic renal failure and renal replacement therapy.
    Drachman R; Schlesinger M; Shapira H; Drukker A
    Pediatr Nephrol; 1989 Jul; 3(3):305-8. PubMed ID: 2702112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients.
    Tilki HE; Akpolat T; Tunali G; Kara A; Onar MK
    Ups J Med Sci; 2004; 109(1):43-8. PubMed ID: 15124952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
    Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
    Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
    Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):463-7. PubMed ID: 15311154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis.
    Chiang CK; Hsu SP; Pai MF; Peng YS; Ho TI; Liu SH; Hung KY; Tsai TJ; Hsieh BS
    Blood Purif; 2005; 23(2):144-8. PubMed ID: 15677863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis.
    Kobayashi S; Maejima S; Ikeda T; Nagase M
    Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
    Bastani B; Chu N
    Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
    Bruun L; Björk T; Lilja H; Becker C; Gustafsson O; Christensson A
    Nephrol Dial Transplant; 2003 Mar; 18(3):598-603. PubMed ID: 12584285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.